Melanoma and microbiota: Current understanding and future directions
Bertrand Routy(Université Paris-Sud), Laurence Zitvogel(Inserm), Geke A.P. Hospers(University Medical Center Groningen), Allyson L. Byrd(National Human Genome Research Institute), Laura Mählmann(Seerave Foundation), Morten L. Isaksen, Hassane M. Zarour(University of Pittsburgh), Ze’ev A. Ronai(Sanford Burnham Prebys Medical Discovery Institute), Diwakar Davar(University of Pittsburgh), Martin J. Blaser(New York University), Kasey L. Couts(University of Colorado Boulder), Gregory D. Sepich‐Poore(University of California San Diego), Kathy D. McCoy(University of Zurich), Sumanta K. Pal(City of Hope), Florent Malard(Sorbonne Université), Lisa Derosa(Université Paris-Sud), Marlies Meisel(University of Pittsburgh), Rinse K. Weersma(University Medical Center Groningen), Randy F. Sweis(National Cancer Institute), Guido Kroemer(Inserm), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Katrine Whiteson(University of California, Irvine), Giorgio Trinchieri(Frederick National Laboratory for Cancer Research), Tanisha Jackson(Melanoma Research Alliance), Fyza Y. Shaikh(Johns Hopkins University), Howard C. Hang(Rockefeller University), Liping Zhao(Hangzhou Normal University), Nathalie Corvaı̈a(Center of Immunology Pierre Fabre), Marcel R.M. van den Brink(Memorial Sloan Kettering Cancer Center), Christina K. Baumgartner(AbbVie (United States)), Eran Segal(Weizmann Institute of Science)
Cited by 78
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Host microbiota constantly control maturation and function of microglia in the CNS
|Nature Neuroscience|2015|3.4k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k